Back to top

February 2021

  /    /  February

The Genitourinary Cancers Symposium, an event organized by the ASCO focused on presenting and debating the latest research, diagnoses and treatment for genitourinary cancer, took place between February 11 and 13 in an online format. LACOG participated by presenting two studies: Bladder Cancer Registry (LACOG 1518) and the APA in Prostate Cancer (LACOG 0415). The first study, presented by Dr. Vinícius Carrera Souza, an oncologists at Instituto D’Or – Bahia, as well as an investigator and executive director for LACOG Genitourinary Group, is centered around creating a multicentric Latin American database to analyze epidemiological, clinical and pathological data; treatment; results and biological information on patients diagnosed with recurrent/metastatic transitional cell carcinoma. The second study, presented by Dr. Andrey Soares, a clinical oncologist at Hospital Israelita Albert Einstein and Centro Paulista de Oncologia and scientific director of LACOG Genitourinary Group, is being conducted with Brazilian patients and assessed several therapeutic options that present fewer adverse events and consequently gains in life quality for individuals under treatment for prostate cancer. For more information and to enroll, visit: https://meetings.asco.org/gu/attend

This report highlights immune checkpoint inhibition with respect to chemotherapy-free regimens and new PD-1 inhibitors. Moreover, different types of therapy for early-stage lung cancer and determinants of treatment success in small-cell lung cancer are covered. Furthermore, innovative and established approaches for patients with uncommon mutations as well as EGFR-targeted options, possibly changing the treatment landscape, are addressed. Last but not least, this special issue includes expert interviews regarding the interactions between radiotherapy and the immune system and the implementation of immunotherapy-based standards for malignant mesothelioma. Additionally, on the memo website you will find expert video interviews with Paul Baas, Tony Mok, Maarten Lambrecht and Byoung Chul Cho on different conference highlights. The memo inOncology Special Issue report is produced by Springer, as a supplement of memo (the Magazine of European Medical Oncology) and sponsored by Boehringer Ingelheim and BeiGene with an unrestricted educational grant. For more information on the memo inOncology Special Issue series, and for free access to all previous editions, visit the memo-inOncology website. Download the ASCO 2020 Lung Cancer report

World Cancer Day World Cancer Day takes place every year on 4th February and is the uniting global initiative under which the world comes together to raise the profile of cancer in a positive and inspiring way. Spearheaded by the Union for International Cancer Control (UICC), the day aims to save millions of preventable deaths each year by raising awareness and improving education about the disease while calling for action from governments and individuals across the world. World Cancer Day 2021 is led by the theme “I Am and I Will”, an empowering call for personal commitment that represents the power of our actions taken now to reduce the growing impact of cancer. Adaptations and innovations in cancer care through COVID-19 and beyond On World Cancer Day, LACOG shines a light on the heroic responses to the pandemic by the local cancer community struggling to maintain progress in cancer care. Marking World Cancer Day on 4th February, LACOG give voice and says thank you to the nurses, doctors, researchers, volunteers, advocates and other caregivers in oncology from around the country, as well as government agencies, who have worked these past 12 months through the COVID-19 pandemic. Led by the Union for International Cancer Control (UICC), the